Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine

Monday, February 8, 2010 General News
Email Print This Page Comment
Font : A-A+

MEDFORD, Mass., Feb. 8 /PRNewswire/ -- Biocell Center announced today its further commitment to working with maternal-fetal-medicine

doctors by attending the Society for Maternal-Fetal Medicine's (SMFM) annual meeting.

"Biocell Center has been working with perinatologists and Ob/Gyn doctors worldwide for several years," said Kate Torchilin, CEO

of Biocell Center Corporation. "We understand the effects that high-risk pregnancy can have on mothers and families and we are hoping to inform women undergoing amniocentesis that they have a unique opportunity to cryopreserve amniotic fluid stem cells as a biological insurance for the future."

Biocell Center Corporation - the only company in the world offering the private preservation of amniotic fluid cells - attended the SMFM meeting in Chicago this week for the first time since it opened for business in the United States in late 2009.

For more information, please contact Laurie Fullerton at laurie.fullerton@biocellcenter.com or call 781-391-2040. Additionally, please go to the Biocell Center website at http://www.biocellcenter.com

This release was issued through eReleases(TM).  For more information, visit http://www.ereleases.com.

SOURCE Biocell Center Corporation



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook